Latest
By Philip Joens / Friday, July 29th, 2016 / Central Coast, Energy, Technology, Top Stories, Top Story / Comments Off on PG&E replacing Diablo Canyon power won’t be easy
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latest
By Staff Report / Wednesday, July 27th, 2016 / Earnings, Latest news, Technology, Tri-County Public Companies / Comments Off on MindBody reports revenue increase, narrows loss in second quarter
San Luis Obispo-based software firm MindBody substantially narrowed its loss for the second quarter, an indication the company’s plan to reach profitability is on track. The company said July 27 that its revenue jumped 36 percent to $33.6 million as its loss, using generally accepted accounting principles or GAAP, narrowed to $6.6 million or 16 Read More →
Latest
By Marissa Nall / Friday, July 22nd, 2016 / Technology, Top Stories, Top Story / Comments Off on Certification gives Apeel appeal
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latest
By Philip Joens / Friday, July 15th, 2016 / East Ventura County, Health Care & Life Science, left, Technology / Comments Off on Amgen wins one, loses one in biosimilar battle
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latest
By Philip Joens / Tuesday, July 12th, 2016 / Health Care & Life Science, Latest news, Technology / Comments Off on FDA panel recommends Amgen biosimilar drug for approval
A Food and Drug Administration panel recommended an Amgen biosimilar drug for approval July 12, just days after it said the biosimilar performed like a drug it mimicked. ABP 501, made by Thousand Oaks biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and Read More →
Latest
By Staff Report / Friday, July 8th, 2016 / Latest news, Technology / Comments Off on Goleta’s Resonant buys GVR Trade SA for $1.1 million
Resonant, a late stage Goleta development company designing small smartphone technology, announced it bought Switzerland-based GVR Trade SA on July 8 for $1.1 million in stock and cash. Resonant designs a smartphone component called a duplexer. The duplexer acts as a phone’s eyes. A set of filters inside the duplexer selects which radio frequencies to Read More →
Latest
By Philip Joens / Friday, July 8th, 2016 / Latest news, Technology / Comments Off on Incubators sprouting in fits and starts
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.